Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, reflecting a minor update to the study record metadata.SummaryDifference0.0%

- Check14 days agoChange DetectedThe study record now shows updated date metadata: the latest update date (2026-08-18) and the QC-verified update date (2026-07-24), along with a revised estimated study completion date (2027-07-23). Older date entries (2026-06-12, 2026-07-11, 2026-06-11) were removed to reflect the new record state.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe site revision label was updated from v3.6.4 to v3.6.5. This represents a minor platform update rather than any change to study details or visible content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, representing a small backend or documentation update. It does not change any study information displayed to users.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates an update to the page template or CMS rather than changes to the study content.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.